Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 4.09 M | $53.74 M | 5.57% | 9.16% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 3.03 M | $39.78 M | 100.00% | 6.78% |
SOFINNOVA INVESTMENTS, INC. | 11/13/2024 | 2.19 M | $28.85 B | 0.00% | 4.92% |
VANGUARD GROUP INC | 11/13/2024 | 2.04 M | $26.77 M | 3.99% | 4.56% |
POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 1.83 M | $24.08 M | 0.00% | 4.10% |
CORMORANT ASSET MANAGEMENT, LP | 11/14/2024 | 1.45 M | $19.07 M | 0.00% | 3.25% |
STATE STREET CORP | 11/14/2024 | 1.21 M | $15.91 M | 50.36% | 2.71% |
CALIGAN PARTNERS LP | 11/14/2024 | 1.20 M | $15.72 M | 105.34% | 2.68% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 813,489 | $10.70 M | 6.25% | 1.82% |
LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 800,000 | $10.52 M | 100.00% | 1.79% |
D. E. SHAW & CO., INC. | 11/14/2024 | 787,536 | $10.36 M | -14.99% | 1.76% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 687,980 | $9.05 M | 4.29% | 1.54% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 557,429 | $7.33 M | 50.92% | 1.25% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 477,664 | $6.28 M | -1.40% | 1.07% |
SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 399,982 | $5.26 M | -38.27% | 0.90% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 279,577 | $3.68 M | 9.38% | 0.63% |
CITADEL ADVISORS LLC | 11/14/2024 | 274,547 | $3.61 M | 4.89% | 0.62% |
MORGAN STANLEY | 11/14/2024 | 248,722 | $3.27 M | 22.44% | 0.56% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 222,600 | $2.93 M | 60.45% | 0.50% |
SQUAREPOINT OPS LLC | 11/14/2024 | 154,931 | $2.04 M | 22.58% | 0.35% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 149,681 | $1.97 M | 0.00% | 0.34% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 136,714 | $1.80 M | -14.79% | 0.31% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 112,483 | $1.48 M | 0.00% | 0.25% |
RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 108,684 | $1.43 M | 21.12% | 0.24% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 105,777 | $1.39 M | -67.27% | 0.24% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 95,383 | $1.25 M | -73.43% | 0.21% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 94,225 | $1.24 M | -46.48% | 0.21% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 91,555 | $1.20 M | -24.31% | 0.21% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 85,000 | $1.12 M | -13.00% | 0.19% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 79,720 | $1.05 M | 78.41% | 0.18% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 76,000 | $999,400 | 0.00% | 0.17% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 71,586 | $941,356 | -79.53% | 0.16% |
BARCLAYS PLC | 11/19/2024 | 69,222 | $910,000 | 433.38% | 0.16% |
FRANKLIN RESOURCES INC | 11/27/2024 | 67,289 | $978,382 | 0.47% | 0.15% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 67,141 | $882,904 | 9.50% | 0.15% |
SWISS NATIONAL BANK | 11/07/2024 | 60,300 | $792,945 | 0.00% | 0.14% |
CAMPBELL & CO INVESTMENT ADVISER LLC | 11/12/2024 | 56,590 | $744,159 | -8.79% | 0.13% |
STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 55,668 | $732,034 | 35.09% | 0.12% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 54,780 | $720,357 | -5.78% | 0.12% |
RHUMBLINE ADVISERS | 11/12/2024 | 52,315 | $687,932 | -3.78% | 0.12% |
UBS GROUP AG | 11/14/2024 | 44,586 | $586,305 | 134.61% | 0.10% |
SAPIENT CAPITAL LLC | 10/11/2024 | 43,700 | $574,655 | 0.00% | 0.10% |
STRS OHIO | 11/01/2024 | 43,400 | $570,710 | 0.00% | 0.10% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 37,695 | $495,690 | 3.05% | 0.08% |
FMR LLC | 11/13/2024 | 36,416 | $478,870 | 23.05% | 0.08% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 35,077 | $461,263 | 100.00% | 0.08% |
ALPS ADVISORS INC | 11/12/2024 | 34,231 | $450,138 | 0.02% | 0.08% |
JPMORGAN CHASE & CO | 12/26/2024 | 30,335 | $398,906 | 10.39% | 0.07% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 11/14/2024 | 29,481 | $387,675 | -3.18% | 0.07% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 27,900 | $366,885 | -56.84% | 0.06% |
Y-mAbs Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:
Paradigm Biocapital Advisors LP: 4.09 M
BlackRock Funding, Inc. /DE: 3.03 M
Sofinnova Investments, Inc.: 2.19 M
VANGUARD GROUP INC: 2.04 M
Polar Capital Holdings Plc: 1.83 M
Cormorant Asset Management, LP: 1.45 M
57.68% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.07 M shares in the last 24 months. This purchase volume represents approximately $200.26 M in transactions.